Concepedia

Publication | Closed Access

Assessment of clinical efficacy of CYT003‐QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study

141

Citations

25

References

2011

Year

Abstract

Treatment with high-dose CYT003-QbG10 improved disease symptoms and reduced medication use in allergic individuals thus providing first evidence for a new potential immunotherapeutic.

References

YearCitations

Page 1